Acadia Healthcare Company Inc ACHC.OQ reported quarterly adjusted earnings of 7 cents per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of 64 cents. The mean expectation of thirteen analysts for the quarter was for earnings of 6 cents per share. Wall Street expected results to range from -2 cents to 45 cents per share.
Revenue rose 6.1% to $821.46 million from a year ago; analysts expected $800.06 million.
Acadia Healthcare Company Inc's reported EPS for the quarter was a loss of $13.02.
The company reported a quarterly loss of $1.18 billion.
Acadia Healthcare Company Inc shares had risen by 21.0% this quarter.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 85.9% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 6 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is also "buy"
Wall Street's median 12-month price target for Acadia Healthcare Company Inc is $17.00, about 1% below its last closing price of $17.17
This summary was machine generated from LSEG data February 25 at 04:12 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Dec. 31 2025 | 0.06 | 0.07 | Beat |
Sep. 30 2025 | 0.67 | 0.72 | Beat |
Jun. 30 2025 | 0.69 | 0.83 | Beat |
Mar. 31 2025 | 0.36 | 0.40 | Beat |
Comments